Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_assertion type Assertion NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_head.
- NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_assertion description "[Acquired mutations in the hematopoietic transcription factor GATA binding protein-1 (GATA1) are found in megakaryoblasts from nearly all individuals with Down syndrome with transient myeloproliferative disorder (TMD, also called transient leukemia) and the related acute megakaryoblastic leukemia (DS-AMKL, also called DS-AML M7).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_provenance.
- NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_assertion evidence source_evidence_literature NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_provenance.
- NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_assertion SIO_000772 15895080 NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_provenance.
- NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_assertion wasDerivedFrom befree-2016 NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_provenance.
- NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_assertion wasGeneratedBy ECO_0000203 NP494902.RA96vbG68rgSD2KmG5O9riH3vC55GuTUJrqjabyyV2Xqg130_provenance.